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Objectives: This study has used a combination of clinical information, spoligotyping, and
georeferencing system to elucidate the genetic diversity of the Mycobacterium tuberculosis
isolates circulating in a TB-prevalent municipality of Northeast Brazil.
Methods: A total of 115 M. tuberculosis strains were isolated from pulmonary tuberculosis
patients from January 2007 to March 2008 in Fortaleza. Drug susceptibility and spoligotyping
assays were performed and place of residence of the patients were georeferenced.
Results: Of the M. tuberculosis strains studied, 51 (44.3%) isolates were resistant to at least one
drug (R-TB) and 64 (55.7%) were sensitive to all the drugs tested (S-TB). A high frequency of
resistance was found in previously treated cases (84%) and among new cases (16%; p<0.001).
A total of 74 (64%) isolates were grouped into 22 spoligotyped lineages, while 41 (36%) iso-
lates were identiﬁed as new. Among the predominant genotypes, 33% were Latim American
Mediterranean (LAM), 12% Haarlem (H), and 5% U. There was no association of geographic
distribution of RT-TB patients as compared to the controls and also the geographic location
to the spoligotype patterns. The geospatial analysis revealed that 24 (23%) patients (hot spotzones) either shared the same residence or lived in a close neighborhood of a case. Amongthese concentration zones, the patients lived in the same residence and shared a common
genotype pattern and resistance pattern.
Discussion: It was observed that the spoligopatterns family distribution was similar to that
reported for South America, prevailing the LAM and H lineages. A high rate-case among the
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resistant TB groupoccurs as a result of transmitted and acquired resistance. Amore effective
surveillance program is needed in order to succeed in reducing tuberculosis in Northeast
Brazil.
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13 Entroduction
rug-resistant Mycobacterium tuberculosis (R-TB) is widespread
n the world, and of particular concern is the occurrence
f multidrug-resistant tuberculosis (MDR-TB), deﬁned as
esistance to at least isoniazid (INH) and rifampicin (RIF).1
esistance may result either from a selection of drug-
esistant organisms (acquired resistance) or infection with a
rug-resistant TB strain (primary resistance). Acquired resis-
ance is responsible for the majority of the cases and is
ell-associated to prior-exposure to anti-TB drugs, which
ncludes those who have relapsed, failed and abandoned
reatment.2
Among all incident cases of TB globally, 3.6% are estimated
o have MDR-TB and 27 countries account for 85% of the MDR-
B cases.3 Despite continuing to be one of the high TB burden
ountries, the prevalence of MDR-TB in Brazil has been esti-
ated to be low;4 surveillance for drug resistance has been
imited.5 In 2009, approximately 87,000 TB caseswere reported
n Brazil with an incidence rate of 45/100,000,4 while in the
tate of Ceará, in 2010, 3430 new cases were reported with an
ncidence of 40.1/100,000.6 Of these TB patients, 87.2% were
ulmonary TB. Fortaleza is the capital city of Ceará and is the
fth largest city in Brazil, with 2.5 million inhabitants. In For-
aleza, the TB incidence has shown a decrease of 1916 in 2005
o 1651 in 2010.6 Thus, implementation and intensiﬁcation
f new strategies in the control program is required in this
egion.
Rapid diagnosis, adequate treatment, and contact trac-
ng to arrest further transmission are important factors
n the control of tuberculosis. Molecular genotyping can
e applied at the population level, and the obtained clus-
ering of isolates provides clues about the patterns and
ynamics of transmission in the population. Moreover when
enotyping is coupled with geographic information system
GIS), the generated data can assess the spatial epidemi-
logy of the disease.7,8 The geographical information can
e correlated with other important data, including clini-
al, drug resistance and genotyping, assisting localization of
iseases and graphical analysis of epidemiological indica-
ors.
There are limited available data regarding drug resistance,
ransmission pattern and strain distribution in North-
ast Brazil. Previous studies of TB in Brazil have been
ostly based on isolated information, including drug resis-
ance, identifying risk factors or genotyping patterns.9–11
combined study based on clinical data, drug resistance
atterns, genotyping and GIS has not been previously
etermined. Thus, we have conducted a study to eluci-
© 20ate the genetic diversity of the M. tuberculosis isolates
irculating in a TB-prevalent municipality of Northeast
razil.Methods
Study population
This was a case–control prospective study conducted from
January 2007 to March 2008 in Fortaleza, Northeast Brazil. Par-
ticipants were recruited at Hospital of Messejana, which is a
reference hospital for TB treatment. On an average, Hospital of
Messejana cares for 130 TB patients per month. The patients
were eligible to participate in the study if they were at least
15 years of age, and had respiratory symptoms or chest X-
ray results suggesting clinical pulmonary TB.12 HIV-infected
patients, pregnant woman and those with no place of resi-
dence were excluded. M. tuberculosis was conﬁrmed by culture
from all the eligible participants. One hundred ﬁfteen partici-
pants entered the study. A reduced number of participants as
compared to the expected were due to the outpatient clinic
of the research physician being open for only one day a week.
No evidence of M. tuberculosis growth or culture contamina-
tion also reduced the total number of participants. Patients
with drug resistant strain to at least one anti-TB drug (R-TB),
were considered as cases. The control group consisted of all
remaining patients infected by fully sensitive M. tuberculosis
(S-TB).
A standardized formwas used to collect data regarding age,
gender, marital status, social behavior and economic status,
clinical, radiological and laboratory tests. All these listed fac-
tors, and others not listed, had been previously identiﬁed to
be related to TB.
Ethical considerations
This project was approved by the Ethical Committee of the
Universidade Federal do Ceará, Fortaleza, CE, Brazil. Written
consent was obtained from each participant.
M. tuberculosis isolation and drug sensitivity testing
Sputum specimens were examined by microscopy and cul-
tured, after decontamination with NaOH and inoculation in
Lowestein–Jensen medium. All the isolates were identiﬁed by
microbiological methods.13 Susceptibility testing for isoniazid
(INH) (0.2g/mL), rifampicin (RMP) (40g/mL), streptomycin
(SM) (4g/mL) and ethambutol (EMB) (2g/mL)was performed
by using the standard proportion method.14
DNA extraction and spoligotyping
DNA extraction was performed by using the hexade-
15,16
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDcyltrimethylammonium bromide (CTAB) method, and
isolates were subjected to spoligotyping.17 The spoligotypes
patterns were converted into binary and octal formats accord-
ing to Brudey et al.18 Spoligopatterns were further analyzed
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Table 1 – Demographic proﬁle and other characteristics of 115 patients with pulmonary tuberculosis.
R-TBan=51 (44.3%) S-TBbn=64 (55.7%) p-Valuec
Age, years (mean/SDc) 39.8/11.2 40.3/15.9 0.858
Gender
Male (n=63) 26 (51.0) 37 (58.0) 0.115
New cases (n = 52) 8 (15.7) 44 (68.8) <0.001
Previous treatment (n = 63) 43 (84.3) 20 (31.2)
Previous TB contact
Yes (n=97) 44 (86.3) 53 (82.8) 0.181
a R-TB, tuberculosis resistant to at least one anti-TB drug.
b
test)
S-TB, tuberculosis sensitivity to the tested drug.
c R-TB was taken as reference for comparison with S-TB (Chi-square
by comparing with SpolDB4 that has been created and
maintained at the Institute Pasteur of Guadeloupe.18,19 Spol-
igotyping results were entered in the Bionumerics Software.
Dendograms were generated using the unweighted pairgroup
method with arithmetic averages (UPGMA) calculation. The
strains with spoligotype similar to any pattern of an M. tuber-
culosis strain already found in the databasewere labeledwith a
deﬁned shared identiﬁcation, while a spoligotyping exhibiting
a proﬁle not yet found was termed “new”.
Geographic information system
Patients were asked to provide their residential addresses and
reference points. Two research assistants were blinded to the
names of the participants and each patient residence was
geo-referenced twice using a GPS handheld device (eTrex®,
Garmin).
The coordinates gathered in the ﬁeld were transcribed to
the Excel spreadsheet and subsequently transformed into PDF
ﬁles to be used directly in the GIS application ArcGIS 9.3 soft-
ware. After the data had been formatted in spreadsheets, the
ArcMap application was used to make the information avail-
able in maps showing the distribution of the georeferenced
cases in Fortaleza according to drug resistance and identiﬁed
family lineage.
Statistical and data analysis
Data were entered in a spreadsheet using Microsoft Excel
(2007) and transferred to SSPS 10.0 version and Epi-info
6.04d for analysis. The Student t-test was used to compare
the means of continuous variables. A non-parametric test
(Mann–Whitney test) was also used to compare data with high
asymmetry. Univariate analyses of the association of clinical,
laboratory and socio-demographic categorical variables were
performed using the Chi-square and Fisher tests. The level of
signiﬁcance was p<0.05.
ResultsA total of one hundred ﬁfteen M. tuberculosis clinical isolates
from pulmonary sources were studied, with 63 (54.8%) males
and 52 (45.2%) females (Table 1). Of these, 51 (44.3%) isolates.
were R-TB and 64 (55.7%) were S-TB. The average age of the
R-TB was 39.8 years (SD 11.2 years; range 20–62 years), while
it was 40.3 years (SD 15.9 years; range 19–82 years) among the
S-TB. Although resistance was not associated to gender, previ-
ously treated cases were more likely among resistant patients
(84.3%), when compared to the control group (31.2%, p<0.001)
(Table 1). Both R-TB and S-TB groups have had history of pre-
vious contact with a TB case, with no signiﬁcant difference
between the two groups (p=0.181).
Overall, 65 (56.5%) clusters of spoligopatterns were shared
by two or more patients (65 clusters containing 2–13 isolates).
Other 50 (43.5%) isolates had unique patterns, designated as
nonclustered (Table 2). No signiﬁcant association was seen
among clustered spoligotypes and non-clustered spoligotypes
and resistance to anti-TBdrugs (p=0.143). Of the 51R-TB cases,
3 (5.9%) were monoresistant to INH, while the remaining 48
(94.1%) were TB-MDR, being more frequent the resistance to
RMP and INH (24/51, 47.1%). None of the isolates had shown
resistance to PZA.
The 115 M. tuberculosis strains were spoligotyped and their
data analyzed using UPGMA calculation in the Bionumerics
software (Table 3 and Fig. 1). The most frequent families found
in the study were Latin American Mediterranean (LAM) (38,
33.0%), Haarlem (H) (14, 12.2%), andU (6, 5.2%). The LAM family
was representedby: 13 (34.2%) LAM9, 10 (26.3%) LAM3, 6 (15.8%)
LAM6, 3 (7.9%) LAM4, 3 (7.9%) LAM5, 2 (5.3%) LAM1, and 1 (2.6%)
LAM11-ZWE. The LAM3 family was in the higher frequency (7
isolates, 43.8%) in the R-TB group as compared to the controls
(3, 13.6%), while LAM9 (8 isolates, 36.4%) was more common
in the control group compared to the R-TB (5, 31.3%). There
were no LAM5 and LAM6 isolates among the R-TB cases. The
H family comprised 12 (10.5%) H3 and 2 (1.7%) H1. Families
East-African-Indian (EAI), H37Rv, Sicily-Sardinia (S), Tuscany
(T), and X comprised 2 (1.7%), 2 (1.7%), 1 (0.9%), 3 (2.6%), and 2
(1.7%) strains, respectively.
Although the reference hospital was in Fortaleza, 10 (8.7%)
patients did not live within the municipality, including two
cases that lived in the states of Maranhão and Piauí, resulting
in a ﬁnal geographic location of 105 pulmonary TB isolates.
Two maps illustrate reported household locations related to
the family lineage identiﬁcation (Fig. 2) and to the resistance to
anti-TB drugs (Fig. 3). Themajority of the cases lived in periph-
eral districts or in poor quality residences of Fortaleza city. The
analysis did not indicate differences among the geographic
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Table 2 – Resistance pattern to ﬁrst line drugs and spoligopatterns among M. tuberculosis isolates from Fortaleza, Brazil.
Total
115 (%)
Clustered spoligotypesa
65 (56.5%)
Nonclustered spoligotypesa
50 (43.5%)
p-Valueb
S-TB 64 (55.7) 37 (56.9) 27 (54.0) 0.143
R-TBc 51 (44.3) 28 (43.1) 23 (46.0)
INH 3 (5.9) 1 (3.6) 2 (8.7)
RMP+ INH 24 (47.1) 12 (42.9) 12 (52.2)
RMP+ INH+EMB 12 (23.5) 9 (32.1) 3 (13.0) 0.158d
RMP+ INH+SM 5 (9.8) 2 (7.1) 3 (13.0)
RMP+ INH+EMB+SM 7 (13.7) 4 (14.3) 3 (13.0)
a Clustered spoligotypes, spoligopatterns shared by two or more patients; nonclustered spoligotypes, single spoligotypes.
b Clustered spoligotypes were taken as reference for comparison with nonclustered spoligotypes (Chi-square test).
l; PZA
polig
d
s
a
t
t
t
p
r
p
s
E
t
R
fc INH, isoniazid; RMP, rifampicin; SM, streptomycin; EMB, ethambuto
d EMB resistance was compared among clustered and nonclustered s
istribution of RT-TB group as compared to controls. In the
ame way, there was no concentration of spoligotype patterns
nd geographic location.
Ahot spot analysis of the patientsmapped by their residen-
ial locations revealed that 24 (22.9%) patients either shared
he same residence or lived in a close neighborhood, less
han 100 meters of distance (Figs. 2 and 3). These overlapped
atients’ zones were labeled by alphabetical letters (A–K), cor-
esponding to 11 spots (Fig. 3). Among these 11 zones, the
atients of spots A, D, E and I lived in the same residence and
hared a common genotype pattern (A and I, LAM3; D, H3 and
, a new cluster). In addition, the spots A and I also shared
he same multidrug-resistance pattern (A, RMP+ INH+EMB; I,
MP+ INH+SM), whereas the other two spots (D and E), were
rom S-TB and R-TB patients.
Table 3 – Distribution of spoligotyping patterns of 115 tuberculo
Family lineagea No. of isolates115 (%)
LAM1 2
LAM3 10
LAM4 3
LAM5 3
LAM6 6
LAM9 13
LAM11-ZWE 1
H1 2
H3 12
U 6
H37Rv 2
T1 2
T3 1
X1 1
X3 1
EAI5 2
S 1
X1-LAM9 1
BRA092001011 Orphan 1
BRA0200000 Rt59 Orphan 1
PRT0219990I93 Orphan 2
ARG012001026-45 Orphan 1
New 41
a Strain genotypes as listed in Fig. 1.
b R-TB, tuberculosis resistant to at least one anti-TB drug.
c S-TB, tuberculosis sensitivity to the tested drug., pyrazinamide.
otypes (Fisher’s exact test).
Discussion
In this study, the genotypic diversity and drug resistance of
M. tuberculosis strains in Northeast Brazil, and also the geo-
graphic distribution of the study sample, were characterized.
It was observed that the spoligopatterns family distribution
was similar to that reported in South America,10,20–23 where
the LAM and H lineages were the most prevalent. It was also
found that 41 (35.7%) isolates that did not match any of the
shared types present in SpolDB4 database. The results further
showed a high rate-case among the resistant TB group as a
result of transmitted and acquired resistance.
It was found a variety of family and subfamilies, which are
also found in other regions of the world.18 These might reﬂect
sis cases.
R-TBb51 (44.3%) S-TBc64 (55.7%)
1 (2.0) 1 (1.6)
7 (13.7) 3 (4.7)
2 (3.9) 1 (1.6)
– 3 (4.7)
– 6 (9.4)
5 8
1 –
– 2
6 6
3 3
2 –
2 –
– 1
– 1
1 –
– 2
– 1
– 1
1 –
1 –
– 2
– 1
19 22
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goty
d paiFig. 1 – Dendogram of Brazilian M. tuberculosis strains. Spoli
Bionumerics software (Applied Maths) using the unweighte
the effects of migratory ﬂow and population mix in Brazil.
As an example, the Haarlem lineage, which was the second-
most frequent in our study, was chronologically originated in
Holland. It is hypothesized that the strain was introduced in
Northeast Brazil during the colonization by the Dutch in the
17th Century. In addition to this, differences were found in
our study regarding some frequency lineages in comparison
to other studies conducted in other regions of the country,
where the T family is described as the second or third-most
prevalent.9,10,21,23pes results from 115 representative strains generated by
r group method of averages (UPGMA).
Conﬁrming to the literature,18,21,24 the LAM family was the
most frequently found in this study, from which the subfamily
LAM9 was the most common. However, our results differ in
the frequency of the other subfamilies of LAM as compared to
other studies conducted in other regions of Brazil such as the
absence of LAM2. The movement of Europeans, at historical
and contemporary time, might explain the presence of LAM3
lineage in Brazil.
Although not signiﬁcant, the fact that some of our isolates
are not commonly found in Brazil such as East African-Indian
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sensitive. Despite MDR-TB outbreaks having been associated
with Beijing and H families,28,29 in our study there was no iso-
lation of Beijing strain and also no association of H family and
R-TB.
It is well-reported that mostly drug-resistant TB can be
generated by either acquired or ampliﬁed resistance, as a con-
sequence of the treatment failure and abandon.30,31 In our
results, despite history of previous treatment being consid-
ered as a risk factor for development of resistant TB bacilli,
a total of 20 (31.2%) patients in the S-TB group reported his-
tory of previous treatment.30,32 Moreover, a high proportion
of MDR-TB cases had a history of previous treatment (84.3%),
due to either irregular treatment or failure, which was much
higher than reported in the literature.33
Many of the reports studying drug resistance rely upon lab-
oratory data based on specimen collection; therefore they do
not identify the true MDR burden at community level. Accord-
ing to WHO Forth global Report, there is an estimation of 3%
of MDR-TB among new cases and 20–40% among previously
treated cases.2 In contrast to that report, we have found a
much higher frequency of MDR-TB rate among the new cases
(15.7%). A previous study conducted in Southeast Brazil has
found a MDR-TB rate of 5.2% among new cases and 16.7%
among previously treated cases.33 Since our samples were
collected by active case-ﬁnding in a reference hospital for
treatment of TB, the high MDR rate among new cases reﬂects
the true importance of surveying this group of patients. In
Fortaleza, the high rate of MDR-TB in new cases is a concern
thatwas not identiﬁed in surveillance reports. Despite someof
the reports associating certain clonal strains and transmitted
TB,29,34 no associationwas seen among the new casesMDR-TB
and the identiﬁed lineages.
The combination of spatial and genotyping data suggested
ongoing neighborhood transmission within the population in
this municipality. The utility of geographic information sys-
tems and spatial analysis has been reported in the literature
for surveillance of TB35–38 and leprosy.8 In our study, at the
district level (ensemble neighborhoods), pulmonary TB cases
were found to be spread over all districts, with some concen-
tration in the south and west of Fortaleza. Population with
high-income live in the North and Northeast of Fortaleza.
These concentrations may reﬂect the underlying heteroge-
neous spatial distribution of socio-economic status.
The positive association between household contacts with
more than one case and TB risk has been reported in previ-
ous studies.39,40 Agreeing to these, in our study a signiﬁcant
association of R-TB and previous treatment was observed.
Furthermore, in nine of the hot spot zones studied, there
were patients who had lost follow-up or failed treatment,
which resulted in household transmission. The loss of follow-
up implies those patients remain contagious, resulting in an
increased risk of the disease within the domicile and in the
neighborhood. Patients who did not complete their treatment
may reﬂect low level of care and poor follow-up system, which
highlight the deﬁciency in health care programs of a low-
income country.Analyzing the geographic location of the studied TB iso-
lates, the genotyping of the isolates and the variables related
to TB (the number of household of more than one case and
clinical history of the case), we suggest that the transmission13;17(3):338–345
is a result of clustered cases and also due to the diffusion
from thenearest neighborhood. In the hot spot zones, patients
were linked into groups of twoor four individuals because they
lived in the same household, or street, or in a nearby street.
Other studies have demonstrated that TB transmission can
occur by casual contact and location of the TB exposure is an
important factor to be considered.41,42 This ﬁnding shows the
importance of geo-referencing studies in order to identify the
MDR-TB spread due to active transmission.
In conclusion, this study highlights the relevant rate of
transmitted resistance among MDR-TB and a typical geo-
graphical pattern of M. tuberculosis strains in Northeast Brazil.
In addition, the study also showed tuberculosis outbreaks by
active transmission of bacilli among clustered cases that gives
this immunocompetent population a high prevalence of TB.
A combination of clinical, spoligotyping and geospatial
analysis to study resistant tuberculosis was successfully
applied, thus demonstrating the utility of this strategy in
tuberculosis control programs. The strain typing patterns of
resistant isolates were useful in providing information about
distribution and epidemiological characteristics, which can be
applied to allow better follow-up of patients, and in deﬁning
strategies for prevention of the disease in prevalent areas.
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